Delivery Order SPE2DB24D9238-SPE2DB24FDQMS
Award Date
8/23/24
Potential Completion Date
9/16/24
Potential Value
$2K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $2,010.76 contract is for the delivery of OZURDEX 0.7 MG IMPLANTS to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group Inc. holds a $499,999,999 single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is valued at $4,006.04 and is for the delivery of OZURDEX 0.7 MG IMPLANTS to support the recurring medical supply needs of military health facilities. The contract has a period of performance through May 9, 2024 and does not have a set-aside designation. This delivery order contract is part of a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,003.02 award is for the delivery of 0.7 mg OZURDEX implants. This order is issued under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA, which provides a comprehensive range of pharmaceutical items to military health facilities worldwide. The...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $3,016.14 contract is for the supply of OZURDEX 0.7 MG IMPLANTS, a specialized pharmaceutical product, to support the recurring medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of OZURDEX 0.7 MG IMPLANTS, with a ceiling value of $3,004.53 and a period of performance through July 17, 2024. The contract is not set aside and is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $2,003.02 contract is for the delivery of OZURDEX 0.7 MG IMPLANTS, a pharmaceutical product. This delivery order is placed against DMS Pharmaceutical Group's larger $4,999,999 indefinite delivery contract with DLA, which enables the agency to issue orders for a broad range of pharmaceutical...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,010.76, is for the delivery of OZURDEX 0.7 MG IMPLANTS, a specialized pharmaceutical product. The contract is not associated with a set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has an award value of $3,016.14 and covers the delivery of OZURDEX 0.7 MG IMPLANTS, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities. The contract is not associated with any set-aside designation, allowing DMS...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the supply of OZURDEX 0.7 MG IMPLANTS, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities. The contract has a ceiling value of $2,010.76 and an ultimate completion date of March 18, 2025. DMS Pharmaceutical Group Inc. holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,004.53 firm fixed-price contract is for the delivery of OZURDEX 0.7 MG IMPLANTS to support the recurring medical supply needs of military health facilities. This contract is not set aside and is part of DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the...